Medipyxis
blog6 min read

Surgical Site Infection in Wound Care: Assessment Guide

Surgical site infection assessment for wound care clinicians — CDC classification, risk factors, culture technique, antibiotic coordination, and documentation.

D

Damon Ebanks

Medipyxis

Surgical Site Infection in Wound Care: Assessment Guide

Surgical Site Infection Assessment in Wound Care Practice

Surgical site infection is one of the most common reasons for post-operative wound care referrals to mobile and outpatient wound care specialists. Patients are discharged from surgical facilities earlier than ever, and the window for SSI development — typically 30 days post-procedure, or up to 90 days for implant-associated infections — frequently falls outside the surgeon's direct observation. That makes the wound care clinician the first to identify, assess, and escalate a developing SSI.

Understanding the CDC classification system, performing appropriate wound cultures, and coordinating antibiotic therapy with the surgical team are core competencies. A misclassified SSI or a poorly collected wound culture leads to wrong-spectrum antibiotics, delayed intervention, and preventable morbidity. This guide covers what the wound care clinician needs to know at the bedside.


CDC Classification of Surgical Site Infections

The CDC classifies SSIs into three categories based on depth and tissue involvement. Each category has distinct diagnostic criteria and management implications.

Superficial Incisional SSI

Involves only the skin and subcutaneous tissue of the incision. Must occur within 30 days of the operative procedure.

Diagnostic criteria (at least one):

  • Purulent drainage from the superficial incision
  • Organisms identified from an aseptically obtained specimen
  • At least one sign of infection: pain/tenderness, localized swelling, erythema, warmth AND the incision is deliberately opened by the surgeon or attending clinician (unless culture-negative)
  • Diagnosis of superficial incisional SSI by the surgeon or attending clinician

What is NOT a superficial SSI:

  • Stitch abscess (minimal inflammation at suture puncture point)
  • Localized stab wound infection
  • Infected burn wound
  • Incisional SSI that extends into fascia and muscle layers (this is deep SSI)

Deep Incisional SSI

Involves the deep soft tissues (fascia, muscle layers) of the incision. Must occur within 30 days (or 90 days if implant present).

Diagnostic criteria (at least one):

  • Purulent drainage from the deep incision
  • Wound spontaneously dehisces or is deliberately opened by the clinician AND the patient has at least one sign: fever (>38 degrees C), localized pain or tenderness (unless culture-negative)
  • Abscess or other evidence of deep tissue infection found on direct examination, imaging, or reoperation
  • Diagnosis of deep incisional SSI by the surgeon or attending clinician

Organ/Space SSI

Involves any part of the body deeper than fascia/muscle that was opened or manipulated during the operative procedure. Examples: intra-abdominal abscess after bowel surgery, mediastinitis after cardiac surgery, joint infection after arthroplasty.

For wound care clinicians: Organ/space SSIs are typically identified via imaging and managed surgically. The wound care clinician's role is to recognize signs that a wound infection may extend beyond what is visible — persistent fevers, disproportionate pain, systemic toxicity despite local wound treatment — and escalate immediately.


Wound Culture Technique in Surgical Site Infections

A poorly collected wound culture is worse than no culture. Surface swabs of wound exudate yield colonizing organisms, not the causative pathogen. The Levine technique is the standard for wound culture collection in the outpatient and mobile setting.

Levine technique protocol:

  1. Cleanse the wound with normal saline — remove surface debris, exudate, and non-viable tissue
  2. Do NOT culture pus, slough, or eschar — these yield colonizers
  3. Identify the area of the wound bed that appears most viable (granulating tissue, or the leading edge of infection)
  4. Press the swab firmly into a 1 cm x 1 cm area of clean wound bed
  5. Rotate the swab with sufficient pressure to express tissue fluid from the wound bed
  6. Hold pressure and rotation for 5 seconds
  7. Place the swab in the transport medium immediately

Common errors:

  • Swabbing wound surface exudate without cleaning first
  • Insufficient pressure — the swab must express tissue fluid, not collect surface bacteria
  • Culturing necrotic tissue (yields polymicrobial environmental flora, not the pathogen)
  • Delayed transport — cultures must reach the lab within the transport medium's viability window

When to obtain cultures:

  • New signs of infection in a previously stable surgical wound
  • Worsening infection despite empiric antibiotics
  • Suspected antibiotic-resistant organism (prior MRSA history, healthcare-associated risk factors)
  • Before initiating antibiotics whenever possible

Proper documentation of culture technique and results is essential. Review the infection assessment documentation guidelines to ensure your clinical notes support the treatment decisions.


Risk Factor Assessment

Identifying patients at elevated SSI risk allows for heightened surveillance and earlier intervention. Document these risk factors at the initial post-surgical wound assessment.

Patient-related risk factors:

  • Diabetes mellitus (particularly with HbA1c >7%)
  • Obesity (BMI >30)
  • Tobacco use
  • Immunosuppression (steroids, chemotherapy, biologics, organ transplant)
  • Malnutrition (albumin <3.0 g/dL)
  • Advanced age
  • Remote site infections at time of surgery

Procedure-related risk factors:

  • Contaminated or dirty wound class at time of surgery
  • Prolonged operative time
  • Emergency surgery vs. elective
  • Implanted foreign material (mesh, hardware, prosthetics)
  • Prior surgery at the same site

Antibiotic Coordination

The wound care clinician identifies and documents the infection. Antibiotic prescribing is coordinated with the surgical team or the patient's primary care provider. This coordination step is where SSI management most frequently breaks down.

Clinician responsibilities:

  • Obtain cultures BEFORE antibiotics are initiated or changed
  • Communicate culture results and wound status to the prescribing provider
  • Document antibiotic regimen, start date, and planned duration in wound care notes
  • Monitor wound response to antibiotics at each visit — if no improvement in 48–72 hours, communicate to the prescribing provider
  • Document systemic signs (fever, elevated WBC if available, malaise) alongside local wound signs

Red flags requiring surgical re-evaluation:

  • Deep or organ/space SSI suspected
  • Wound dehiscence with visible fascia or deeper structures
  • Failure to improve after 5–7 days of appropriate antibiotics
  • New onset of systemic sepsis signs

Documentation and Audit Risk

SSI documentation in wound care notes is subject to scrutiny from multiple directions: infection control reporting, quality metrics, and payer audits. Maintaining thorough records reduces documentation audit risk and supports defensible clinical decisions.

Document at every visit:

  • CDC classification (superficial, deep, or suspected organ/space)
  • Wound measurements, tissue type, exudate character, and periwound condition
  • Culture collection: date, technique used, site cultured, results when available
  • Antibiotic regimen and prescribing provider
  • Communication with surgical team (date, provider name, information conveyed)
  • Patient education on signs of worsening infection and when to call

Key Takeaways

  • Use the CDC three-tier classification (superficial incisional, deep incisional, organ/space) to categorize every SSI accurately — misclassification leads to wrong treatment intensity and flawed reporting
  • Wound cultures must use the Levine technique on cleaned, viable tissue: surface swabs of exudate yield colonizers, not pathogens
  • Obtain cultures before starting antibiotics whenever possible, and communicate results to the prescribing provider with documented follow-up
  • Risk factor assessment at the initial post-surgical visit enables appropriate surveillance intensity and supports clinical decision-making
  • Document CDC classification, culture technique, antibiotic coordination, and surgical team communication at every visit to reduce audit risk and liability exposure

Want to learn more about Medipyxis?

Explore how mobile wound care practices use Medipyxis to reduce denials and capture more referrals.